CASTLE BIOSCIENCES INC cotiza a 32.88 USD y tiene una capitalización bursátil de $1.0B. En los últimos 12 meses ha facturado $357M con un margen de flujo de caja libre del 8.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.07 | $-0.49 | $-0.08 |
| Estimado | $-0.35 | $-0.41 | $-0.49 | $-0.26 |
| Sorpresa | — | +82.9% | +0.0% | +69.2% |
| Métrica | CSTL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 79.4% | 57.0% | +22.3% |
| Operating Margin | -12.4% | -38.6% | +26.2% |
| Net Margin | -7.0% | -33.6% | +26.5% |
| FCF Margin | 8.2% | -13.9% | +22.1% |
| ROE | -5.1% | -40.4% | +35.3% |
| ROA | -4.2% | -32.0% | +27.8% |
| Current Ratio | 5.26 | 2.84 | +2.42 |
| Debt / Equity | 0.02 | 0.28 | -0.26 |